胆道癌存活率的最近5年趋势:一个分析的大数据调查调查
1Department of Biostatistics, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Medicine international
|January 30, 2025
概括
胆道癌 (BTC) 存活率有所改善,结果受癌症位置和糖尿病等并发症的影响. 与其他BTC类型相比,胆囊癌的预后较差.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 胆管癌 (BTC) 或胆管癌是一种罕见的恶性瘤,在历史上预后不佳.
- 尽管化疗和向疗法取得了进展,但对BTC的综合结果研究仍然有限.
- 了解生存趋势对于改善患者管理和治疗策略至关重要.
研究的目的:
- 分析2015年至2020年间被诊断为胆道癌 (BTC) 的患者的生存趋势.
- 研究解剖位置和并发症对BTC患者死亡率的影响.
- 评估研究期间整体和1年死亡率的变化.
主要方法:
- 利用来自国家公共数据库的匿名数据,包括13,600名被诊断为BTC的患者.
- 分析了整体和1年死亡率,按BTC解剖部位分层 (肝内,肝外,胆囊).
- 通过使用危险比率 (HR) 评估了伴随疾病 (糖尿病,肝炎) 和胆囊结石对生存的影响.
主要成果:
- 总体生存率从2018年开始有所改善,从2015年到2019年,1年生存危险比率下降.
- 与肝内BTC相比,胆囊癌的1年生存率 (HR=0.349) 显著较低.
- 糖尿病与死亡率增加有关 (HR=1.318),而胆囊结石显示出改善生存率的趋势 (HR=0.902).
结论:
- 国家大数据分析表明,自2018年以来,胆道癌症患者的预后有所改善.
- BTC预后受到癌症的解剖位置和伴随疾病的存在的显著影响.
- 糖尿病等同时存在的疾病会对生存率产生负面影响,这强调了综合患者护理的必要性.
更多相关视频
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
5.6K
13:57Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
92
相关概念视频
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...